Both in Biotechnology
Allogene Therapeutics vs REGENXBIO
Over the past year ALLO returned −7.6% and RGNX returned −40.3%; their daily moves had a correlation of 0.36.
ALLO −7.6% RGNX −40.3%Growth of $1, one year, split-adjusted
| Metric | ALLO | RGNX |
|---|---|---|
| Price | $1.09 | $7.16 |
| Market cap | $376.6M | $472.7M |
| Today | −7.63% | −0.56% |
| 1 month | −27.3% | −3.6% |
| 6 months | −51.8% | −23.7% |
| Year to date | −20.4% | −50.3% |
| 1 year | −9.9% | −44.1% |
| Revenue growth (YoY) | — | +405.7% |
| Gross margin | 100.0% | 99.0% |
| Net margin | −919.8% | 21.0% |
| P/E (TTM) | — | — |
| Price / sales | 81.2× | 2.7× |
| Net cash | $332.6M | $105.5M |
| Dividend yield | — | — |
| Volatility (60d) | 55.0% | 86.1% |
| Short % of float | 19.4% | 19.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).